Cytokinetics
CYTK
CYTK
249 hedge funds and large institutions have $3.99B invested in Cytokinetics in 2021 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 84 increasing their positions, 79 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
18% more funds holding
Funds holding: 211 → 249 (+38)
6% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 79
0.88% more ownership
Funds ownership: 108.08% → 108.96% (+0.88%)
Holders
249
Holding in Top 10
10
Calls
$9.79M
Puts
$5.51M
Top Buyers
| 1 | +$76.4M | |
| 2 | +$38M | |
| 3 | +$25.6M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$15.2M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$14.8M |
Top Sellers
| 1 | -$33.2M | |
| 2 | -$31.7M | |
| 3 | -$25.6M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$25.6M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$21.2M |